The North American life science instrumentation market is estimated to grow at a CAGR of around 6.4% during the forecast period. The market is mainly driven due to growing life-science research activities, technological advancement in sequencing technologies, significant adoption of the cell culture in the US and Canada. Moreover, the growing adoption of personalized medicine in the region further provides a significant opportunity to the market. Furthermore, The North American life science instrumentation market is segmented on the basis of technology and end-user.
Based on the technology, the market is further classified into chromatography, spectroscopy, polymerase chain reaction (PCR), clinical chemistry analyzers, immunoassays, next-generation sequencing (NGS), flow cytometry, microscopy, and others (centrifuges, electrophoresis). The NGS segment is projected to have considerable growth during the forecast period owing to the increasing application in sequencing for cancer-based research. Based on the end-user, the North American life science instrumentation market is further segmented into pharmaceutical & biotechnology companies, research institutes, and hospitals &laboratories. The pharmaceutical & biotechnology companies segment estimated to grow at a considerable CAGR during the forecast. Based on geography, the North American life science instrumentation market is further segregated into the US and Canada. Among, geography, the US hold a considerable share in the North American life science instrumentation market.
Furthermore, the North American life science instrumentation market is characterized by the presence of several market players that are catering to a wide range of customers across the globe. Some of the key players in the market include Agilent Technologies, Inc., Becton, Dickinson and Co., Bio-Rad Laboratories, Inc., Danaher Corp., Illumina, Inc., Thermo Fisher Scientific, Inc. and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launch, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.
Research Methodology
The market study of the North American life science instrumentation market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for life science instrumentation market players, the medical device industry, contract manufacturers, research institutes, distributors & traders, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the North American Life Science Instrumentation Industry
• Recovery Scenario of North American Life Science Instrumentation Industry
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. North American Life Science Instrumentation Market by Technology
5.1.1. Chromatography
5.1.2. Spectroscopy
5.1.3. Polymerase Chain Reaction (PCR)
5.1.4. Clinical Chemistry Analyzers
5.1.5. Immunoassays
5.1.6. Next Generation Sequencing (NGS)
5.1.7. Flow Cytometry
5.1.8. Microscopy
5.1.9. Others(Centrifuges, Electrophoresis)
5.2. North American Life Science Instrumentation Market by End-User
5.2.1. Pharmaceutical & Biotechnology Companies
5.2.2. Research Institutes
5.2.3. Hospitals and Laboratories
6. Regional Analysis
6.1. United States
6.2. Canada
7. Company Profiles
7.1. Agilent Technologies, Inc.
7.2. Becton, Dickinson and Co.
7.3. Bio-Rad Laboratories, Inc.
7.4. Bruker Corp.
7.5. Danaher Corp.
7.6. General Electric Co.
7.7. Illumina, Inc.
7.8. PerkinElmer Inc.
7.9. Thermo Fisher Scientific Inc.
7.10. Waters Corp.
1. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
2. NORTH AMERICAN CHROMATOGRAPHY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
3. NORTH AMERICAN SPECTROSCOPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
4. NORTH AMERICAN POLYMERASE CHAIN REACTION (PCR) MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
5. NORTH AMERICAN CLINICAL CHEMISTRY ANALYZERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
6. NORTH AMERICAN NEXT GENERATION SEQUENCING (NGS) MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
7. NORTH AMERICAN FLOW CYTOMETRY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
8. NORTH AMERICAN MICROSCOPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
9. NORTH AMERICAN OTHERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
10. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
11. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
12. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
13. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION IN HOSPITALS AND LABORATORIES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
14. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
15. US LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
16. US LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
17. CANADA LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
18. CANADA LIFE SCIENCE INSTRUMENTATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET, 2020-2027 (%)
4. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
5. NORTH AMERICAN CHROMATOGRAPHY MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
6. NORTH AMERICAN SPECTROSCOPY MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
7. NORTH AMERICAN POLYMERASE CHAIN REACTION (PCR) MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
8. NORTH AMERICAN CLINICAL CHEMISTRY ANALYZERS MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
9. NORTH AMERICAN NEXT GENERATION SEQUENCING (NGS) MARKET SHARE BY COUNTRY,2020 VS 2027 (%)
10. NORTH AMERICAN FLOW CYTOMETRY MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
11. NORTH AMERICAN FLOW MICROSCOPY MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
12. NORTH AMERICAN FLOW OTHERS MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
13. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET SHARE BY END-USER, 2020 VS 2027 (%)
14. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
15. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION IN RESEARCH INSTITUTES MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
16. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION IN HOSPITALS AND LABORATORIES MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
17. NORTH AMERICAN LIFE SCIENCE INSTRUMENTATION MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
18. US LIFE SCIENCE INSTRUMENTATION MARKET SIZE, 2020-2027 ($ MILLION)
19. CANADA LIFE SCIENCE INSTRUMENTATION MARKET SIZE, 2020-2027 ($ MILLION)